These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6869022)

  • 1. Release and inhibition of uptake of 5-hydroxytryptamine in blood platelets in vitro by copper and methyl mercury.
    Tuomisto J; Komulainen H
    Acta Pharmacol Toxicol (Copenh); 1983 Apr; 52(4):292-7. PubMed ID: 6869022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of 5-hydroxytryptamine uptake in rabbit hypothalamic synaptosomes but not in blood platelets by zinc and lead ex vivo.
    Komulainen H
    Acta Pharmacol Toxicol (Copenh); 1983 Aug; 53(2):166-74. PubMed ID: 6624484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of heavy metals on monoamine uptake and release in brain synaptosomes and blood platelets.
    Komulainen H; Tuomisto J
    Neurobehav Toxicol Teratol; 1982; 4(6):647-9. PubMed ID: 7170022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Bondiolotti GP; Galva MD; Villa F; Sciaba L; Picotti GB
    Biochem Pharmacol; 1995 Jun; 50(1):97-102. PubMed ID: 7605351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake, release, and subcellular localization of 1-methyl-4-phenylpyridinium in blood platelets.
    Cesura AM; Ritter A; Picotti GB; Da Prada M
    J Neurochem; 1987 Jul; 49(1):138-45. PubMed ID: 3495635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca-dependence of accumulation of monoamines into synaptosomes and its inhibition by copper.
    Tuomisto J; Komulainen H
    Acta Pharmacol Toxicol (Copenh); 1983 Sep; 53(3):193-9. PubMed ID: 6138919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of aspirin on 5-hydroxytryptamine uptake and release by human platelets.
    Rendu F
    Br J Pharmacol; 1976 May; 57(1):149-51. PubMed ID: 1276534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of N-ethylmaleimide on 5-hydroxytryptamine transport and sodium content in rabbit platelets.
    Wölfel R; Halbrügge T; Graefe KH
    Br J Pharmacol; 1989 Aug; 97(4):1308-14. PubMed ID: 2790384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of blood platelets as a model for CNS response: comparative effects of caffeine on 5-HT uptake and release mechanisms in rat platelets and rat brain serotonin neurons.
    Chou DT; Cuzzone H; Hirsh KR
    Life Sci; 1983 Sep; 33(12):1149-56. PubMed ID: 6888169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fenfluramine on 5-hydroxytryptamine uptake and release by rat blood platelets.
    Buczko W; De Gaetano G; Garattini S
    Br J Pharmacol; 1975 Apr; 53(4):563-8. PubMed ID: 1148499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin and dietary amines may increase plasma 5-hydroxytryptamine in the horse.
    Bailey SR; Cunningham FM; Elliott J
    Equine Vet J; 2000 Nov; 32(6):497-504. PubMed ID: 11093623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of 5-hydroxytryptamine in blood platelets and its inhibition by drugs: role of plasma membrane and granular storage.
    Laubscher A; Pletscher A
    J Pharm Pharmacol; 1979 May; 31(5):284-9. PubMed ID: 37296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets and biogenic amines. 2. Indications for a discrete low affinity uptake mechanism shared by norepinephrine and 5-hydroxytryptamine in human platelets.
    Malmgren R
    Psychopharmacology (Berl); 1986; 90(3):384-9. PubMed ID: 3097728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Content and subcellular localization of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma.
    Da Prada M; Picotti GB
    Br J Pharmacol; 1979 Apr; 65(4):653-62. PubMed ID: 571302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin and dopamine uptake by human blood platelets.
    Airaksinen MM; Svensk H; Tuomisto J; Komulainen H
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):308-13. PubMed ID: 7368950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Hydroxytryptamine uptake and release in relation to aggregation of rabbit platelets.
    Baumgartner HR
    J Physiol; 1969 Apr; 201(2):409-23. PubMed ID: 5780550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cadmium treatment in vitro on the uptake and release of [3H]serotonin by human blood platelets.
    Mukhopadhyay S; Mukhopadhyay S; Addya S; Bhattacharya DK; Chatterjee GC
    Indian J Biochem Biophys; 1989 Feb; 26(1):56-60. PubMed ID: 2777314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin at therapeutic concentrations does not affect 5-hydroxytryptamine uptake by platelets.
    Drummond AH; MacIntyre DE; Olverman HJ
    Br J Pharmacol; 1977 Apr; 59(4):661-2. PubMed ID: 858010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxytryptamine and dopamine transport by rat and human blood platelets.
    Gordon JL; Olverman HJ
    Br J Pharmacol; 1978 Feb; 62(2):219-26. PubMed ID: 623937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.